Showing results (311-320 of 583) with videos related to
Sort By:
Pageof 59
Surgery Today|October 22, 2013
Early discontinuation of adjuvant hormone therapy is associated with a poor prognosis in Japanese breast cancer patientsKenji Taketani, Eriko Tokunaga, Nami Yamashita, et al.Oncology|September 12, 2024
Clinical Impact of Skeletal Muscle Mass and Nutritional Status in Patients with Recurrent or Advanced Gastric Cancer Treated with NivolumabQingjiang Hu, Kensuke Kudo, Takafumi Yukaya, et al.Cancer Chemotherapy and Pharmacology|July 30, 2016
Multicenter phase II study of combination therapy with cetuximab and S-1 in patients with KRAS exon 2 wild-type unresectable colorectal cancer previously treated with irinotecan, oxaliplatin, and fluoropyrimidines (KSCC 0901 study)Takao Takahashi, Yasunori Emi, Eiji Oki, et al.International Journal of Clinical Oncology|September 3, 2021
Infusion-related reaction to ramucirumab plus FOLFIRI in patients with advanced colorectal cancerHiroyuki Okuyama, Yoshinori Kagawa, Toshiki Masuishi, et al.Anticancer Research|April 13, 2016
Laparoscopic Resection of Gastric Cancer in a Patient with Chronic Lymphocytic Leukemia Accompanied by NeutropeniaYuichiro Nakashima, Ryota Nakanishi, Masahiko Sugiyama, et al.Cancer Science|March 29, 2021
Monitoring FTD in the peripheral blood mononuclear cells of elderly patients with metastatic colorectal cancer administered FTD plus bevacizumab as first-line treatmentYoshiaki Fujimoto, Eiji Oki, Shichao Qiu, et al.Surgery Today|August 2, 2014
Esophagectomy-related thoracic duct injury detected by lymphoscintigraphy with 99mTc-diethylenetriamine pentaacetic acid-human serum albumin: report of a caseYasuo Tsuda, Masaru Morita, Hiroshi Saeki, et al.Surgery Today|December 15, 2012
Sarcomatoid carcinoma of the remnant stomach: report of a caseAiko Sato, Eiji Oki, Hidenori Kohso, et al.Surgery Today|September 10, 2013
Impact of second-line and later cetuximab-containing therapy and KRAS genotypes in patients with metastatic colorectal cancer: a multicenter study in JapanHiroshi Saeki, Yasunori Emi, Ryuichi Kumashiro, et al.Cancer Medicine|January 10, 2014
Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancerEriko Tokunaga, Yuichi Hisamatsu, Kenji Taketani, et al.Pageof 59